Compound information
- Natural Products
- NACP42879
- Molecular Formula
- C24H35NO2
- Molecular Weight
- 369.26677936 g/mol
- Structure
-
- IUPAC Name
- 1-icosa-5,8,11,14-tetraenylpyrrole-2,5-dione
- InChI
- InChI=1S/C24H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22-25-23(26)20-21-24(25)27/h6-7,9-10,12-13,15-16,20-21H,2-5,8,11,14,17-19,22H2,1H3
- InChI Key
- GZNZRHSGGQUYAP-UHFFFAOYSA-N
- SMILES
- O=C1C=CC(=O)N1CCCCC=CCC=CCC=CCC=CCCCCC
- CAS
- SuperClass
- Organoheterocyclic compounds
- Class
- Pyrrolidines
- SubClass
- Pyrrolidones
- Source
- CNP0347548
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 37.38 Å2 | LogP | 7.184 |
LogS | -6.916 | LogD | 5.408 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.997 | Pgp substrate | 0.0 |
HIA | 0.936 | F20 % | 0.99 |
F30 % | 0.628 | Caco-2 | -4.586 |
MDCK | -4.228 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.018 | PPB | 88.505 |
VD | 0.991 | Fu | 2.018 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.582 | CYP1A2 substrate | 0.312 |
CYP2A6 substrate | 0.261 | CYP2B6 substrate | 0.346 |
CYP2C19 inhibitor | 0.135 | CYP2C19 substrate | 0.375 |
CYP2C8 substrate | 0.47 | CYP2C9 inhibitor | 0.739 |
CYP2C9 substrate | 0.052 | CYP2D6 inhibitor | 0.065 |
CYP2D6 substrate | 0.304 | CYP2E1 substrate | 0.411 |
CYP3A4 inhibitor | 0.36 | CYP3A4 substrate | 0.006 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.685 | CL | 6.224 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.974 | Hepatotoxicity | 0.197 |
Mutagenicity | 0.635 | Rat Oral Acute Toxicity | 0.001 |
FDAMDD | 0.55 | Skin Sensitization | 0.987 |
Carcinogenicity | 0.123 | Eye Corrosion | 0.988 |
Eye Irritation | 0.923 | Respiratory Toxicity | 0.556 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.548 | IGC50 | 4.285 |
LC50FM | 6.394 | LC50DM | 6.286 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.316 | NR-AR-LBD | 0.233 |
NR-AhR | 0.017 | NR-Aromatase | 0.531 |
NR-ER | 0.519 | NR-ER-LBD | 0.396 |
NR-PPAR-gamma | 0.825 | SR-ARE | 0.87 |
SR-ATAD5 | 0.452 | SR-HSE | 0.941 |
SR-MMP | 0.974 | SR-p53 | 0.787 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.